Sign in
4

Changes in Ownership

Opus Genetics, Inc. Filed Acc 0001140361-18-044426

Options or other derivatives

  • Director acquired 112,878 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Price Ben Gil · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2018-11-29 Grant or award : show line 1 in the form Stock Option (right to buy) +112,878 $1.10 2028-11-29 112,878 112,878 D
Loading xslF345X03/form4.xml…